Now, pop a pill to prevent HIV?

We seem to be a step closer to eradicating HIV with the United States’ Food and Drug Administration on Tuesday approving  a drug  to be used in healthy people as a preventive measure for the infection.

The drug, Trudeau vada (commonly known as Truvada), has been used by patients already infected with the virus that ultimately leads to AIDs.

But now the FDA has cleared the drug for use by high-risk groups. The drug panel feels that the pills, if taken daily, by  those who are highly active sexually will stall HIV infection. A study conducted from 2010 shows that the pills can also serve as the preventing the spread of the virus in a high-risk healthy population, those who risk coming  into contact with HIV.

Truvada is made by California-based Gilead Sciences and  combines two medicines that inhibit the reproduction of HIV.

However, the FDA approval has brought dissent from certain groups who disapprove of the use of  Truvada in healthy people as the drug causes bone thinning and may also lead to kidney problems later.  They feel that the FDA should go on an overdrive, instead,  to promote safe sex practices as a means to prevent HIV infection.